FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕

Dr. med. Hanhan Liu appointed as new CCSP fellow

Hanhan Liu

Augenklinik

Dr. med. Hanhan Liu finished her medical studies at Tongji University in Shanghai in June 2013. After that, she worked for 2 years as an Ophthalmology resident at the Ophthalmology Department of Shanghai East Hospital and finished her master thesis.

Immediately after her master’s thesis in 2015, Dr. Hanhan Liu applied as a doctoral student in Univ.-Prof. Dr. Verena Prokosch`s work group neuroprotection at the University Eye Hospital in Mainz. Dr. Hanhan Liu successfully completed her doctorate on the subject of „Neuroprotection from hydrogen sulfide in glaucoma“ with magna cum laude.

Her highly ranked publication in Investigative Ophthalmology & Visual Science was the first to demonstrate that H2S provides dose-dependent protection in different animal models of glaucoma, both in vitro and in vivo, and the underlying mechanisms of the protective effect of H2S is related to the regulation of iron metabolism, mitochondrial dynamics and vascular functions. For this work, Dr. Hanhan Liu received the Glaucoma Research Award from the German Ophthalmology Association (DOG) in 2018. She continued to work on the topic and published five peer-reviewed papers as first author on the subject of H2S and neuroprotection in glaucoma. For the paper “Mitochondrial Changes and Aging in Glaucoma” she received the Paper of the Month in April 2020 from the World Glaucoma Association.

Last October, Dr. Hanhan Liu followed Prof. Prokosch’s professorship to the University Eye Clinic of Cologne and started her follow-up project “Hydrogen Sulfide: an experimental study of its properties on neuroprotective treatment strategies in glaucoma” as a postdoc in Prokosch’s work group neuroprotection in glaucoma.
In this project, they expect to shed light on the pathophysiology of glaucoma and to better understand the protective mechanism of H2S in retinal neurodegeneration. Researches into the protective mechanism of H2S will open up the possibility of novel, neuroprotective treatment strategies for glaucoma.
In January 2021, Dr. Hanhan Liu won the scientific prize of the Rheinisch-Westfälischer Augenärzte association for this project.

After a significant boost to her expertise in basic research, Dr. Hanhan Liu will continue her training as a specialist in ophthalmology at the University Eye Clinic of Cologne. It will be undeniably challenging to work in the clinic and still maintain the scientific track.
The Cologne Clinician Scientist program provides the perfect opportunity for young clinician-scientists to optimally balance their resources on clinical work and research at the same time. In the course of CCSP, she will be working under the supervision and mentoring of both Prof. Dr. Prokosch and Prof. Dr. Claus Cursiefen.

Related posts

July 28, 2023

Modern laboratory – microscope donated


Read more
January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more

News

  • SFB 1607 Launches Website and Celebrates TEO-C New Lab Location
  • New SFB 1607 Launched – Building on the Foundations of FOR2240
  • Faculty prize for PD Dr. Schrittenlocher – Awarded for best habilitation in 2022
  • DOG poster award for Dr. Martina Maaß
  • Young Cologne Eye Researcher Šejla Gegić won Margarete Kramer Prize

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.SchließenDatenschutzerklärung